Bi, Y., Wei, H., Ma, Q., Wang, R., Jin, J., Qu, K., . . . Wang, J. (2025). The fragility index of randomized controlled trials in advanced/metastatic renal cell cancer. Urologic Oncology, 43(5), 333. https://doi.org/10.1016/j.urolonc.2025.03.003
Chicago Style (17th ed.) CitationBi, Yingwei, et al. "The Fragility Index of Randomized Controlled Trials in Advanced/metastatic Renal Cell Cancer." Urologic Oncology 43, no. 5 (2025): 333. https://doi.org/10.1016/j.urolonc.2025.03.003.
MLA (9th ed.) CitationBi, Yingwei, et al. "The Fragility Index of Randomized Controlled Trials in Advanced/metastatic Renal Cell Cancer." Urologic Oncology, vol. 43, no. 5, 2025, p. 333, https://doi.org/10.1016/j.urolonc.2025.03.003.
Warning: These citations may not always be 100% accurate.